Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - Updated revision tag from v3.0.1 to v3.0.2. - Removed the Back to Top link.
    Difference
    0.1%
    Check dated 2025-09-16T19:51:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page version has been updated from v3.0.0 to v3.0.1 and a Back to Top navigation element has been added.
    Difference
    0.1%
    Check dated 2025-09-09T15:23:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as additional drug information and publications related to ovarian cancer treatments. Notably, the publication dates have been updated to reflect new research findings.
    Difference
    33%
    Check dated 2025-09-02T10:45:30.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-11T22:06:02.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.8 to version 2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-04T19:28:59.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page has been updated to include a new HHS Vulnerability Disclosure and has been revised to version 2.16.8. The previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-07-28T15:28:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.